Ranbaxy Q1 by Epic Research

Consolidated Net Loss At Rs 186 Crore Versus Loss Of Rs 524.2 Crore (YoY)



Consolidated Revenue At Rs 2,426.2 Crore Versus Rs 2,634.2 Crore (YoY)



Consolidated EBITDA At Rs 238 Crore Versus Rs 200 Crore (YoY)



Consolidated Operating Margin At 9.8 percent Versus 7.6 percent (YoY)



Consolidated Settlement Provision At Rs 237.7 Crore



Real Time News & Trading Trends Keep Liking #EpicResearch




Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

Posted in: Indian Market Tips